1. Pharmacogenomics for the efficacy of platinum-based chemotherapy: Old drugs, new integrated perspective
   Chen-Xue Mao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
2. The influence of genetic polymorphisms on the toxicity of platinum-based chemotherapy in the treatment of non-small cell lung cancer
   Jelena Spasić et al, 2021, Medicinski podmladak CrossRef
3. Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients: A Field Synopsis and Meta‐Analysis
   Hilary Sito et al, 2024, British Journal of Biomedical Science CrossRef
4. Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy
   M. Joerger et al, 2015, Cancer Chemotherapy and Pharmacology CrossRef
5. Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1
   Gerhard Hamilton et al, 2018, Expert Opinion on Drug Metabolism & Toxicology CrossRef
6. The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
   Joshua T. Burgess et al, 2020, Frontiers in Oncology CrossRef
7. Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
   Cristina Pérez-Ramírez et al, 2017, Mutation Research/Reviews in Mutation Research CrossRef
8. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients
   Cristina Pérez-Ramírez et al, 2019, The Pharmacogenomics Journal CrossRef
9. RETRACTED ARTICLE: ArticleNoteEvaluation and simulation of medical sports health equipment multimedia image based on information asymmetry theory
   Rong Li, 2020, Multimedia Tools and Applications CrossRef
10. Association of genes involved in nicotine and tobacco smoke toxicant metabolism (CHRNA3/5, CYP2A6, and NQO1) and DNA repair (XRCC1, XRCC3, XPC, and XPA) with chronic obstructive pulmonary disease
    G. F. Korytina et al, 2014, Molecular Biology CrossRef
11. Pharmacogenomics of Platinum-Based Chemotherapy Sensitivity in NSCLC: Toward Precision Medicine
    Ji-Ye Yin et al, 2016, Pharmacogenomics CrossRef
12. XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies
    Tianxin Xiang et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef
13. Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
    Marianna Macerelli et al, 2016, Cancer Treatment Reviews CrossRef
14. A functional single‐nucleotide polymorphism in the ERCC 1 gene alters the efficacy of narrowband ultraviolet B therapy in patients with active vitiligo in a Chinese population
    W. Dai et al, 2015, British Journal of Dermatology CrossRef
15. Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis
    Li-Ming Tan et al, 2017, Scientific Reports CrossRef
16. Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
    Ruud H. Wijdeven et al, 2016, Drug Resistance Updates CrossRef
17. Base Excision Repair and Nucleotide Excision Repair
    T. Izumi et al, 2016, Genome Stability CrossRef
18. Base excision repair and nucleotide excision repair
    Tadahide Izumi et al, 2021, Genome Stability CrossRef
19. Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
    Edwin P. Hui et al, 2015, Cancer CrossRef
20. The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck cancers: A systematic review and meta-analysis
    Yang Gao et al, 2015, Oral Oncology CrossRef
21. Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems
    Yi Xiong et al, 2017, Medical Oncology CrossRef